Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer
Academic Article
Overview
MeSH Major
Adenocarcinoma
Lymph Node Excision
Pancreatic Neoplasms
Randomized Controlled Trials as Topic
abstract
Definitive evaluation of the potential benefits of extended lymphadenectomy would require a prohibitively large sample size. Adequately powered randomized trials to address the potential benefit of extended lymphadenectomy are infeasible.
